Chiline CATCH® Circulating Tumor Cell Test

Regular Monitoring for Health Protection

Chiline CATCH® Circulating Tumor Cell Test

Regular Monitoring for Health Protection

Circulating Tumor Cells

(CTCs)

CTCs are cancer cells that shed from primary or metastatic tumors and enter the bloodstream.
These cells circulate through the blood, travel to distant organs and tissues, and may form new tumors, leading to cancer metastasis.

Detectable Cancer Types

Detectable Cancer Types

Product Advantages

Sample Collection Process

Sample Collection Process

Data and Significance

CTC 追蹤表
受檢者循環腫瘤細胞數量建議
一般健康者<5每6個月定期追蹤一次
>5建議就醫
每3–6個月定期追蹤一次
癌症患者治療中<5每6個月定期追蹤一次
>5遵照醫師指示進行療程
完成治療<5每3–6個月定期追蹤一次
>5每1–3個月定期追蹤一次

Real-time cancer recurrence monitoring helps understand whether the disease is in remission or worsening.

  • Upward Trend: Increased risk of cancer recurrence
  • Downward Trend: Decreased risk of cancer recurrence

Data and Significance

CTC 追蹤表
受檢者循環腫瘤細胞數量建議
一般健康者<5每6個月定期追蹤一次
>5建議就醫
每3–6個月定期追蹤一次
癌症患者治療中<5每6個月定期追蹤一次
>5遵照醫師指示進行療程
完成治療<5每3–6個月定期追蹤一次
>5每1–3個月定期追蹤一次

Real-time cancer recurrence monitoring helps understand whether the disease is in remission or worsening.

  • Upward Trend: Increased risk of cancer recurrence
  • Downward Trend: Decreased risk of cancer recurrence

Chiline CATCH® Circulating Tumor Cell Test

Regular Monitoring for Health Protection

Circulating Tumor Cells

(CTCs)

CTCs are cancer cells that shed from primary or metastatic tumors and enter the bloodstream.

Detectable Cancer Types

Product Advantages

Sample Collection Process

Data and Significance

CTC 追蹤表
受檢者循環腫瘤細胞數量建議
一般健康者<5每6個月定期追蹤一次
>5建議就醫
每3–6個月定期追蹤一次
癌症患者治療中<5每6個月定期追蹤一次
>5遵照醫師指示進行療程
完成治療<5每3–6個月定期追蹤一次
>5每1–3個月定期追蹤一次

Real-time cancer recurrence monitoring helps understand whether the disease is in remission or worsening.

  • Upward Trend: Increased risk of cancer recurrence
  • Downward Trend: Decreased risk of cancer recurrence